首页 > 最新文献

中华男科学杂志最新文献

英文 中文
[Treatment of male immune infertility by traditional Chinese medicine: A meta-analysis]. [中药治疗男性免疫性不育:荟萃分析]。
Q4 Medicine Pub Date : 2024-06-01
Chun-Mei Fan, Si-Qi Ma, Ke-Fan Ding, Yi-Jian Yang, Xin-Bang Wen, Zi-Qin Zhao, Shu-Hui Chen, Guo-Zheng Qin

Objective: To evaluate the efficacy and safety of traditional Chinese medicine (TCM) in the treatment of male immune infertility (MII) by meta-analysis.

Methods: We retrieved randomized controlled trial (RCT) on the treatment of male immune infertility with traditional Chinese medicine from the databases of WanFang, Chinese Biomedical Literature, Cochrane Library, Weipu, PubMed and CNKI, and performed methodological quality assessment of the RCTs identified and statistical analysis and evaluation of the publication bias using the RevMan5.4 software.

Results: Totally, 25 RCTs (2 563 cases) were included in this study. Compared with Western medicine alone in the treatment of MII, TCM achieved a significantly higher total effectiveness rate (OR = 6.35, 95% CI: 4.96-8.13, P<0.000 01), negative conversion rate of seminal plasma anti-sperm antibodies (OR = 4.52, 95% CI: 2.72 - 7.51, P<0.000 01), negative rate of serum anti-sperm antibodies (OR = 2.98, 95% CI: 2.23-3.96, P<0.000 01), sperm concentration (MD = 15.56, 95% CI: 11.32-19.79, P<0.000 01), grade a sperm motility (MD = 3.85, 95% CI: 1.91-5.79, P=0.000 01), grade a+b sperm motility (MD = 13.77, 95% CI: 7.06-20.48, P<0.000 1), sperm viability (MD = 10.32, 95% CI: 6.78-13.86, P<0.000 01) and pregnancy rate (OR = 3.53, 95% CI: 2.68-4.63, P<0.000 01), but a lower rate of adverse reactions (OR = 0.06, 95% CI: 0.01-0.23, P<0.000 01). There was no statistically significant difference in the percentage of morphologically abnormal sperm between TCM and Western medicine alone in the treatment of MII (MD = -7.53, 95% CI: -15.50-0.44, P = 0.06).

Conclusion: TCM has a definite effectiveness and high safe in the treatment of male immune infertility.

目的:通过荟萃分析评估中药治疗男性免疫性不育症(MII)的有效性和安全性:通过荟萃分析评价中药治疗男性免疫性不育症(MII)的有效性和安全性:方法:从万方数据库、中国生物医学文献数据库、Cochrane图书馆、维普数据库、PubMed数据库和CNKI数据库中检索中药治疗男性免疫性不育的随机对照试验(RCT),使用RevMan5.4软件对RCT进行方法学质量评估、统计分析和发表偏倚评价:结果:本研究共纳入25项RCT(2 563例)。与单纯西药治疗 MII 相比,中医药的总有效率明显更高(OR = 6.35,95% CI:4.96-8.13,PConclusion):中医治疗男性免疫性不育疗效确切,安全性高。
{"title":"[Treatment of male immune infertility by traditional Chinese medicine: A meta-analysis].","authors":"Chun-Mei Fan, Si-Qi Ma, Ke-Fan Ding, Yi-Jian Yang, Xin-Bang Wen, Zi-Qin Zhao, Shu-Hui Chen, Guo-Zheng Qin","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Objective: </strong>To evaluate the efficacy and safety of traditional Chinese medicine (TCM) in the treatment of male immune infertility (MII) by meta-analysis.</p><p><strong>Methods: </strong>We retrieved randomized controlled trial (RCT) on the treatment of male immune infertility with traditional Chinese medicine from the databases of WanFang, Chinese Biomedical Literature, Cochrane Library, Weipu, PubMed and CNKI, and performed methodological quality assessment of the RCTs identified and statistical analysis and evaluation of the publication bias using the RevMan5.4 software.</p><p><strong>Results: </strong>Totally, 25 RCTs (2 563 cases) were included in this study. Compared with Western medicine alone in the treatment of MII, TCM achieved a significantly higher total effectiveness rate (OR = 6.35, 95% CI: 4.96-8.13, P<0.000 01), negative conversion rate of seminal plasma anti-sperm antibodies (OR = 4.52, 95% CI: 2.72 - 7.51, P<0.000 01), negative rate of serum anti-sperm antibodies (OR = 2.98, 95% CI: 2.23-3.96, P<0.000 01), sperm concentration (MD = 15.56, 95% CI: 11.32-19.79, P<0.000 01), grade a sperm motility (MD = 3.85, 95% CI: 1.91-5.79, P=0.000 01), grade a+b sperm motility (MD = 13.77, 95% CI: 7.06-20.48, P<0.000 1), sperm viability (MD = 10.32, 95% CI: 6.78-13.86, P<0.000 01) and pregnancy rate (OR = 3.53, 95% CI: 2.68-4.63, P<0.000 01), but a lower rate of adverse reactions (OR = 0.06, 95% CI: 0.01-0.23, P<0.000 01). There was no statistically significant difference in the percentage of morphologically abnormal sperm between TCM and Western medicine alone in the treatment of MII (MD = -7.53, 95% CI: -15.50-0.44, P = 0.06).</p><p><strong>Conclusion: </strong>TCM has a definite effectiveness and high safe in the treatment of male immune infertility.</p>","PeriodicalId":24012,"journal":{"name":"Zhonghua nan ke xue = National journal of andrology","volume":"30 6","pages":"547-563"},"PeriodicalIF":0.0,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142112805","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Action mechanisms of Qianlie Jindan Tablets on chronic nonbcterial prostatitis in rats: An exploration based on non-targeted urine metabolomics]. [千里光金丹片对大鼠慢性非细菌性前列腺炎的作用机制:基于非靶向尿液代谢组学的探索]。
Q4 Medicine Pub Date : 2024-06-01
Teng-Fei Chen, Zhi-Chao Jia, Zhuo-Zhuo Shi, Jun-Guo Ma, Xiao-Lin Li, Chong-Fu Zhong

Objective: To explore the mechanisms of Qianlie Jindan Tablets (QLJD) acting on chronic nonbacterial prostatitis (CNP) in rats based on non-targeted urine metabolomics.

Methods: According to the body mass index, we equally randomized 30 eight-week-old male SD rats into a blank control, a CNP model control and a QLJD medication group. We established the CNP model in the latter groups and, from the 4th day of modeling, treated the rats in the blank and model control groups intragastrically with normal saline and those in the QLJD medication group with QLJD suspension, qd, for 30 successive days. Then we detected the changes in the metabolites of the rats by ultra-high-performance liquid chromatography-tandem mass spectrometry, and identified the differential metabolites in different groups by multivariate statistical analysis, followed by functional annotation of the differential metabolites.

Results: Eight common metabolites were identified by metabolomics analysis, of which 5 were decreased in the CNP model controls and increased in the QLJD medication group, while the other 3 increased in the former and decreased in the latter group. Creatinine and genistein were important differential metabolites, and the arginine and proline metabolic pathways and isoflavone biosynthesis pathways were the main ones for QLJD acting on CNP. Compared with the blank controls, the model controls showed up-regulated arginine and proline metabolic pathways, increased production of creatinine, down-regulated isoflavone biosynthetic pathway and decreased production of genistein. The above changes in the model controls were all reversed in the QLJD medication group.

Conclusion: QLJD acts effectively on CNP in male rats by regulating L-arginine and proline metabolic pathways, as well as the isoflavone biosynthesis pathway and naringenin metabolism.

目的基于非靶向尿液代谢组学,探讨千里光金丹片(QLJD)对大鼠慢性非细菌性前列腺炎(CNP)的作用机制:将30只8周龄雄性SD大鼠按体重指数平均分为空白对照组、CNP模型对照组和QLJD药物组。从建模第 4 天起,空白对照组和模型对照组大鼠腹腔注射生理盐水,QLJD 药物组大鼠腹腔注射 QLJD 悬浮液,连续 30 天。然后,我们通过超高效液相色谱-串联质谱法检测了大鼠代谢物的变化,并通过多元统计分析确定了不同组别的差异代谢物,随后对差异代谢物进行了功能注释:结果:代谢组学分析确定了8种常见代谢物,其中5种在CNP模型对照组中减少,而在QLJD药物组中增加,另外3种在前者中增加,而在后者中减少。肌酐和染料木素是重要的差异代谢物,精氨酸和脯氨酸代谢途径以及异黄酮生物合成途径是QLJD作用于CNP的主要途径。与空白对照组相比,模型对照组的精氨酸和脯氨酸代谢途径上调,肌酐生成增加,异黄酮生物合成途径下调,染料木素生成减少。模型对照组的上述变化在 QLJD 药物组中全部逆转:结论:QLJD通过调节L-精氨酸和脯氨酸代谢途径,以及异黄酮生物合成途径和柚皮苷代谢,对雄性大鼠的CNP产生有效作用。
{"title":"[Action mechanisms of Qianlie Jindan Tablets on chronic nonbcterial prostatitis in rats: An exploration based on non-targeted urine metabolomics].","authors":"Teng-Fei Chen, Zhi-Chao Jia, Zhuo-Zhuo Shi, Jun-Guo Ma, Xiao-Lin Li, Chong-Fu Zhong","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Objective: </strong>To explore the mechanisms of Qianlie Jindan Tablets (QLJD) acting on chronic nonbacterial prostatitis (CNP) in rats based on non-targeted urine metabolomics.</p><p><strong>Methods: </strong>According to the body mass index, we equally randomized 30 eight-week-old male SD rats into a blank control, a CNP model control and a QLJD medication group. We established the CNP model in the latter groups and, from the 4th day of modeling, treated the rats in the blank and model control groups intragastrically with normal saline and those in the QLJD medication group with QLJD suspension, qd, for 30 successive days. Then we detected the changes in the metabolites of the rats by ultra-high-performance liquid chromatography-tandem mass spectrometry, and identified the differential metabolites in different groups by multivariate statistical analysis, followed by functional annotation of the differential metabolites.</p><p><strong>Results: </strong>Eight common metabolites were identified by metabolomics analysis, of which 5 were decreased in the CNP model controls and increased in the QLJD medication group, while the other 3 increased in the former and decreased in the latter group. Creatinine and genistein were important differential metabolites, and the arginine and proline metabolic pathways and isoflavone biosynthesis pathways were the main ones for QLJD acting on CNP. Compared with the blank controls, the model controls showed up-regulated arginine and proline metabolic pathways, increased production of creatinine, down-regulated isoflavone biosynthetic pathway and decreased production of genistein. The above changes in the model controls were all reversed in the QLJD medication group.</p><p><strong>Conclusion: </strong>QLJD acts effectively on CNP in male rats by regulating L-arginine and proline metabolic pathways, as well as the isoflavone biosynthesis pathway and naringenin metabolism.</p>","PeriodicalId":24012,"journal":{"name":"Zhonghua nan ke xue = National journal of andrology","volume":"30 6","pages":"531-539"},"PeriodicalIF":0.0,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142112781","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Application of single-sperm sequencing in resolving the carrier status of preimplantation genetic testing for chromosomal structural rearrangements in Robertsonian translocations]. [单精子测序在解决罗伯逊易位染色体结构重排植入前基因检测携带者状态中的应用]。
Q4 Medicine Pub Date : 2024-06-01
Bao-Qiong Liao, Li-Dan Lai, Ru-Tian Liu, Qi Zhang, Wen-Chang Lian, Wu-Ming Xie

Objective: To investigate the application value of single-sperm sequencing in resolving the carrier status of preimplantation genetic testing (PGT) for chromosomal structural rearrangements in Robertsonian translocations.

Methods: Haplotypes were constructed by single-sperm isolation combined with single-sperm sequencing for a patient with 45, XY, der(13; 14)(q10; q10). Twenty single-sperm samples were isolated by mechanical braking and subjected to whole-genome amplification (WGA), and then the Asian Screening Array (ASA) gene chip was used to detect the 183 708 single nucleotide polymorphisms (SNP) of the WGA products. The single sperm associated with the translocation that could be used as haplotype inference was detected by copy number variation (CNV) sequencing, and the chromosomal haplotypes with normal and Robertsonian translocations were inferred. Three biopsy samples of embryonic trophoblast cells were used as the objects. After whole-genome amplification, high-throughput sequencing was employed to determine the status of the translocation chromosome carried by the embryos. The available blastocysts were selected for transfer, and the amniotic fluid samples were taken at 18 weeks of gestation to confirm whether the fetus carried the pathogenic mutation.

Results: A total of 6 037 SNP sites were screened by single-sperm sequencing, and 30 sites selected to distinguish normal and translocation haplotypes. Preimplantation haplotype analysis showed that all the three embryos were euploids without Robertsonian translocation chromosome. Genetic testing of amniotic fluid in the second trimester confirmed that the karyotype of the fetus was 46, XN, carrying no Robertsonian translocation chromosome.

Conclusion: For male carriers of Robertsonian translocation, single sperm sequencing can be used to screen SNP sites to construct haplotypes for distinguishing normal and Robertsonian translocation embryos, and to provide a basis for embryo selection by preimplantation chromosomal structural genetic testing.

目的研究单精子测序在解决罗伯逊易位染色体结构重排的植入前基因检测(PGT)携带者状态中的应用价值。方法:通过单精子分离结合单精子测序,为一名45, XY, der(13; 14)(q10; q10)患者构建单倍型。通过机械制动分离了 20 个单精子样本,并对其进行了全基因组扩增(WGA),然后使用亚洲筛查阵列(ASA)基因芯片检测了 WGA 产物中的 183 708 个单核苷酸多态性(SNP)。通过拷贝数变异(CNV)测序,检测出与易位相关的、可用于单倍型推断的单个精子,并推断出正常易位和罗伯逊易位的染色体单倍型。以三份胚胎滋养层细胞活检样本为对象。在进行全基因组扩增后,利用高通量测序确定胚胎携带的易位染色体的状态。选择可用的囊胚进行移植,并在妊娠18周时采集羊水样本,以确认胎儿是否携带致病突变:结果:通过单精子测序共筛选出 6 037 个 SNP 位点,并选择了 30 个位点来区分正常单倍型和易位单倍型。植入前单倍型分析表明,三个胚胎均为无罗伯逊易位染色体的优倍体。第二孕期羊水基因检测证实,胎儿的核型为 46,XN,不携带罗伯逊易位染色体:对于罗伯逊易位的男性携带者,单精子测序可用于筛选SNP位点,构建单倍型以区分正常胚胎和罗伯逊易位胚胎,并为胚胎植入前染色体结构基因检测的胚胎选择提供依据。
{"title":"[Application of single-sperm sequencing in resolving the carrier status of preimplantation genetic testing for chromosomal structural rearrangements in Robertsonian translocations].","authors":"Bao-Qiong Liao, Li-Dan Lai, Ru-Tian Liu, Qi Zhang, Wen-Chang Lian, Wu-Ming Xie","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Objective: </strong>To investigate the application value of single-sperm sequencing in resolving the carrier status of preimplantation genetic testing (PGT) for chromosomal structural rearrangements in Robertsonian translocations.</p><p><strong>Methods: </strong>Haplotypes were constructed by single-sperm isolation combined with single-sperm sequencing for a patient with 45, XY, der(13; 14)(q10; q10). Twenty single-sperm samples were isolated by mechanical braking and subjected to whole-genome amplification (WGA), and then the Asian Screening Array (ASA) gene chip was used to detect the 183 708 single nucleotide polymorphisms (SNP) of the WGA products. The single sperm associated with the translocation that could be used as haplotype inference was detected by copy number variation (CNV) sequencing, and the chromosomal haplotypes with normal and Robertsonian translocations were inferred. Three biopsy samples of embryonic trophoblast cells were used as the objects. After whole-genome amplification, high-throughput sequencing was employed to determine the status of the translocation chromosome carried by the embryos. The available blastocysts were selected for transfer, and the amniotic fluid samples were taken at 18 weeks of gestation to confirm whether the fetus carried the pathogenic mutation.</p><p><strong>Results: </strong>A total of 6 037 SNP sites were screened by single-sperm sequencing, and 30 sites selected to distinguish normal and translocation haplotypes. Preimplantation haplotype analysis showed that all the three embryos were euploids without Robertsonian translocation chromosome. Genetic testing of amniotic fluid in the second trimester confirmed that the karyotype of the fetus was 46, XN, carrying no Robertsonian translocation chromosome.</p><p><strong>Conclusion: </strong>For male carriers of Robertsonian translocation, single sperm sequencing can be used to screen SNP sites to construct haplotypes for distinguishing normal and Robertsonian translocation embryos, and to provide a basis for embryo selection by preimplantation chromosomal structural genetic testing.</p>","PeriodicalId":24012,"journal":{"name":"Zhonghua nan ke xue = National journal of andrology","volume":"30 6","pages":"499-506"},"PeriodicalIF":0.0,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142112782","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Genetic analysis of carriers of complex chromosome rearrangement]. [复杂染色体重排携带者的遗传分析]。
Q4 Medicine Pub Date : 2024-06-01
Hao Tian, Min-Jie Shao, Li-Ying Yan, Jie Qiao

Objective: To comprehensively analyze the numbers of involved chromosomes and breakpoints and the clinical phenotypes of the patients with complex chromosome rearrangement (CCR).

Methods: We selected 23 745 patients with abnormal fertility seeking medical care in the Center of Reproductive Medicine of Peking University Third Hospital from 2011 to 2015, and analyzed their peripheral blood chromosomal karyotypes using G-banding, C-banding and fluorescence in situ hybridization (FISH).

Results: A total of 28 CCR carriers (0.118%) were detected among the 23 745 patients with abnormal fertility, including 18 males mainly with azoospermia or oligoasthenospermia and 10 females mainly with infertility, recurrent abortion, embryo termination and abnormal birth. Of the 28 cases of CCR, tripartite rearrangement was found in 9 (32.14%), double translocation in 7 (25%) and special translocation in 12 (42.86%). CCR carrier-related chromosomes were all involved but chromosomes 12 and 19, while 2 and 5 were involved most frequently.

Conclusion: At present, the incidence of CCR is low. CCR carriers with normal phenotypes are often found because of reproductive problems, and their low chance of having a normal baby necessitates the use of preimplantation genetic test to improve the rate of live birth. Due to the diversity of the chromosomes and breakpoints involved in CCR, it is crucial to give each CCR carrier precise genetic counseling.

目的全面分析复杂染色体重排(CCR)患者受累染色体数、断点数及临床表型:方法:选取2011年至2015年在北京大学第三医院生殖医学中心就诊的23 745例生育异常患者,采用G-带、C-带和荧光原位杂交(FISH)技术对其外周血染色体核型进行分析:结果:在23 745例生育异常患者中,共发现28例CCR携带者(0.118%),其中男性18例,主要表现为无精子症或少精子症;女性10例,主要表现为不孕、反复流产、胚胎终止和异常分娩。在 28 例 CCR 患者中,发现三方重排的有 9 例(32.14%),双易位的有 7 例(25%),特殊易位的有 12 例(42.86%)。CCR携带者相关染色体全部受累,但第12和19号染色体受累最多,而第2和5号染色体受累最多:结论:目前,CCR 的发病率较低。结论:目前,CCR 的发病率较低,表型正常的 CCR 携带者往往是因为生殖问题而被发现,他们生出正常婴儿的几率较低,因此有必要使用植入前基因检测来提高活产率。由于 CCR 所涉及的染色体和断裂点的多样性,为每个 CCR 携带者提供精确的遗传咨询至关重要。
{"title":"[Genetic analysis of carriers of complex chromosome rearrangement].","authors":"Hao Tian, Min-Jie Shao, Li-Ying Yan, Jie Qiao","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Objective: </strong>To comprehensively analyze the numbers of involved chromosomes and breakpoints and the clinical phenotypes of the patients with complex chromosome rearrangement (CCR).</p><p><strong>Methods: </strong>We selected 23 745 patients with abnormal fertility seeking medical care in the Center of Reproductive Medicine of Peking University Third Hospital from 2011 to 2015, and analyzed their peripheral blood chromosomal karyotypes using G-banding, C-banding and fluorescence in situ hybridization (FISH).</p><p><strong>Results: </strong>A total of 28 CCR carriers (0.118%) were detected among the 23 745 patients with abnormal fertility, including 18 males mainly with azoospermia or oligoasthenospermia and 10 females mainly with infertility, recurrent abortion, embryo termination and abnormal birth. Of the 28 cases of CCR, tripartite rearrangement was found in 9 (32.14%), double translocation in 7 (25%) and special translocation in 12 (42.86%). CCR carrier-related chromosomes were all involved but chromosomes 12 and 19, while 2 and 5 were involved most frequently.</p><p><strong>Conclusion: </strong>At present, the incidence of CCR is low. CCR carriers with normal phenotypes are often found because of reproductive problems, and their low chance of having a normal baby necessitates the use of preimplantation genetic test to improve the rate of live birth. Due to the diversity of the chromosomes and breakpoints involved in CCR, it is crucial to give each CCR carrier precise genetic counseling.</p>","PeriodicalId":24012,"journal":{"name":"Zhonghua nan ke xue = National journal of andrology","volume":"30 6","pages":"493-498"},"PeriodicalIF":0.0,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142112786","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Xiaozheng Granules combined with Jingqiankang Bacteriostatic Gelatin for chronic prostatitis with damp-heat and blood stasis: A clinical observation based on infrared thermography]. [小正方颗粒联合京前康抑菌明胶治疗湿热瘀血型慢性前列腺炎:基于红外热成像的临床观察]。
Q4 Medicine Pub Date : 2024-06-01
Peng Ma, Qi Zhang, Gui-Feng Chang, Zu-Long Wang

Objective: To evaluate the clinical efficacy of Xiaozheng Granules (XZG) combined with Jingqiankang Bacteriostatic Gelatin (JBG) on chronic prostatitis of the damp-heat and blood-stasis type based on infrared thermography (IRT).

Methods: This study included 120 cases of chronic prostatitis with damp-heat and blood stasis treated in the First Affiliated Hospital of Henan University of Chinese Medicine with oral XZG (the control group, n = 60) or oral XZG combined with anal administration of JBG (the trial group, n = 60), both for 4 weeks. We obtained the NIH-CPSI and traditional Chinese medicine (TCM) syndrome scores of the patients, measured the temperatures in the belt-vessel, lower focal and inguinal regions by IRT before and after treatment, recorded the adverse reactions during the treatment, and compared them between the two groups of patients.

Results: Compared with the baseline, the NIH-CPSI and TCM syndrome scores were significantly decreased in the two groups of patients after treatment (P < 0.05), even more significantly in the trial than in the control group (P < 0.05), and after 1 hour of treatment, the temperatures in the Xiajiao ([34.09 ± 0.34] vs [33.60 ± 0.40] ℃, P < 0.05) and the groin region ([34.49 ± 0.28] vs [33.78 ± 0.30] ℃, P < 0.05) were remarkably reduced in the trial group, but showed no significant change in the control group (Xiajiao region: [34.02 ± 0.29] vs [34.05 ± 0.26] ℃, P > 0.05; groin region: [34.54 ± 0.25] vs [34.51±0.22] ℃, P > 0.05). After 4 weeks of treatment, the temperatures in the Xiajiao and groin regions were even lower in the trial ([33.13 ± 0.41] ℃ and [33.21 ± 0.29] ℃) and the control group ([33.42±0.25] ℃ and [33.86±0.29] ℃) than the baseline and those after 1 hour of treatment (P < 0.05), and still more significantly in the former than in the latter group (P < 0.05). The total effectiveness rate was markedly higher in the trial group than in the control (88.14% vs 77.19%, P < 0.05), and no obvious adverse reactions were observed in neither group.

Conclusion: XZG combined with JBG is a safe and effective treatment of chronic prostatitis with damp-heat and blood-stasis, which can significantly reduce the NIH-CPSI and TCM syndrome scores and IRT temperatures in the lower focal and inguinal regions of the patients.

目的根据红外热像图(IRT)评价小青颗粒联合精谦康抑菌明胶(JBG)对湿热血瘀型慢性前列腺炎的临床疗效:本研究纳入河南中医药大学第一附属医院收治的120例湿热血瘀型慢性前列腺炎患者,采用口服XZG(对照组,n = 60)或口服XZG联合肛门给药JBG(试验组,n = 60)治疗,疗程均为4周。我们获得了患者的NIH-CPSI和中医证候评分,通过IRT测量了治疗前后带脉、下焦和腹股沟区域的温度,记录了治疗期间的不良反应,并对两组患者进行了比较:与基线相比,两组患者治疗后NIH-CPSI和中医综合征评分均明显下降(P<0.05),试验组甚至明显高于对照组(P<0.05),治疗1小时后,下焦温度([34.09±0.34] vs [33.60±0.40] ℃,P<0.05)和腹股沟区([34.49 ± 0.28] vs [33.78 ± 0.30] ℃,P<0.05)明显降低,但对照组无明显变化(下焦区:[34.02±0.29] vs [34.05±0.26]℃,P>0.05;腹股沟区:[34.54±0.25] vs [34.51±0.22]℃,P>0.05)。治疗4周后,试验组下焦和腹股沟区温度更低([33.13±0.41] ℃和[33.21±0.29] ℃),对照组([33.42±0.25] ℃和 [33.86±0.29] ℃)均高于基线值和治疗1小时后(P<0.05),且前者仍明显高于后者(P<0.05)。试验组的总有效率明显高于对照组(88.14% vs 77.19%,P < 0.05),两组均未观察到明显的不良反应:结论:XZG联合JBG治疗慢性前列腺炎湿热血瘀证安全有效,可显著降低患者NIH-CPSI、中医综合征评分及下焦、腹股沟区IRT温度。
{"title":"[Xiaozheng Granules combined with Jingqiankang Bacteriostatic Gelatin for chronic prostatitis with damp-heat and blood stasis: A clinical observation based on infrared thermography].","authors":"Peng Ma, Qi Zhang, Gui-Feng Chang, Zu-Long Wang","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Objective: </strong>To evaluate the clinical efficacy of Xiaozheng Granules (XZG) combined with Jingqiankang Bacteriostatic Gelatin (JBG) on chronic prostatitis of the damp-heat and blood-stasis type based on infrared thermography (IRT).</p><p><strong>Methods: </strong>This study included 120 cases of chronic prostatitis with damp-heat and blood stasis treated in the First Affiliated Hospital of Henan University of Chinese Medicine with oral XZG (the control group, n = 60) or oral XZG combined with anal administration of JBG (the trial group, n = 60), both for 4 weeks. We obtained the NIH-CPSI and traditional Chinese medicine (TCM) syndrome scores of the patients, measured the temperatures in the belt-vessel, lower focal and inguinal regions by IRT before and after treatment, recorded the adverse reactions during the treatment, and compared them between the two groups of patients.</p><p><strong>Results: </strong>Compared with the baseline, the NIH-CPSI and TCM syndrome scores were significantly decreased in the two groups of patients after treatment (P < 0.05), even more significantly in the trial than in the control group (P < 0.05), and after 1 hour of treatment, the temperatures in the Xiajiao ([34.09 ± 0.34] vs [33.60 ± 0.40] ℃, P < 0.05) and the groin region ([34.49 ± 0.28] vs [33.78 ± 0.30] ℃, P < 0.05) were remarkably reduced in the trial group, but showed no significant change in the control group (Xiajiao region: [34.02 ± 0.29] vs [34.05 ± 0.26] ℃, P > 0.05; groin region: [34.54 ± 0.25] vs [34.51±0.22] ℃, P > 0.05). After 4 weeks of treatment, the temperatures in the Xiajiao and groin regions were even lower in the trial ([33.13 ± 0.41] ℃ and [33.21 ± 0.29] ℃) and the control group ([33.42±0.25] ℃ and [33.86±0.29] ℃) than the baseline and those after 1 hour of treatment (P < 0.05), and still more significantly in the former than in the latter group (P < 0.05). The total effectiveness rate was markedly higher in the trial group than in the control (88.14% vs 77.19%, P < 0.05), and no obvious adverse reactions were observed in neither group.</p><p><strong>Conclusion: </strong>XZG combined with JBG is a safe and effective treatment of chronic prostatitis with damp-heat and blood-stasis, which can significantly reduce the NIH-CPSI and TCM syndrome scores and IRT temperatures in the lower focal and inguinal regions of the patients.</p>","PeriodicalId":24012,"journal":{"name":"Zhonghua nan ke xue = National journal of andrology","volume":"30 6","pages":"540-546"},"PeriodicalIF":0.0,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142112806","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Mechanisms of traditional Chinese medicine in the treatment of chronic nonbacterial prostatitis]. [中药治疗慢性非细菌性前列腺炎的机理]。
Q4 Medicine Pub Date : 2024-06-01
Da-Lin Sun, Bao-Fang Jin

Chronic nonbacterial prostatitis (CNP) is one of the most common diseases in urology and andrology, with a complex etiology and a high incidence rate. Traditional Chinese medicine plays an important role in the treatment of CNP and can produce therapeutic effects through various action mechanisms. This article presents an overview of recent studies on the specific mechanisms of traditional Chinese medicine acting on CNP, including the mechanisms underlying its effects of anti-infection, anti-inflammation, immune regulation, improvement of urodynamics, endocrine regulation, improvement of microcirculation, and regulation of gut microbiota, aiming to provide some reference for the clinical application and basic studies of traditional Chinese medicine in the treatment of CNP.

慢性非细菌性前列腺炎(CNP)是泌尿外科和泌尿外科最常见的疾病之一,病因复杂,发病率高。中药在治疗慢性非细菌性前列腺炎方面发挥着重要作用,可通过多种作用机制产生疗效。本文综述了近年来关于中药作用于 CNP 的具体机制的研究,包括中药抗感染、抗炎、免疫调节、改善尿动力学、调节内分泌、改善微循环、调节肠道微生物群等作用机制,旨在为中药治疗 CNP 的临床应用和基础研究提供一些参考。
{"title":"[Mechanisms of traditional Chinese medicine in the treatment of chronic nonbacterial prostatitis].","authors":"Da-Lin Sun, Bao-Fang Jin","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Chronic nonbacterial prostatitis (CNP) is one of the most common diseases in urology and andrology, with a complex etiology and a high incidence rate. Traditional Chinese medicine plays an important role in the treatment of CNP and can produce therapeutic effects through various action mechanisms. This article presents an overview of recent studies on the specific mechanisms of traditional Chinese medicine acting on CNP, including the mechanisms underlying its effects of anti-infection, anti-inflammation, immune regulation, improvement of urodynamics, endocrine regulation, improvement of microcirculation, and regulation of gut microbiota, aiming to provide some reference for the clinical application and basic studies of traditional Chinese medicine in the treatment of CNP.</p>","PeriodicalId":24012,"journal":{"name":"Zhonghua nan ke xue = National journal of andrology","volume":"30 6","pages":"564-568"},"PeriodicalIF":0.0,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142112789","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Intervention of traditional Chinese medicine in spermatogenic epithelium injury by regulating the ferroptosis pathway: Advances in studies]. [中药通过调节铁凋亡通路干预生精上皮损伤:研究进展]。
Q4 Medicine Pub Date : 2024-05-01
Jin-Tao Wei, Zi-Yang Ma, Jun Cao, Pei-Hai Zhang

The incidence of male infertility has been increasing year by year, and one of the major causes is testicular spermatogenic epithelial injury, which affects the spermatogenic function of the testis. Ferroptosis is a novel mode of cell death and plays an important role in testicular cell injury. Some traditional Chinese medicines can intervene in the progression of testicular injury by regulating the ferroptosis pathway in testicular spermatogenic epithelia. This paper focuses on the effect of traditional Chinese drugs in regulating the ferroptosis pathway in testicular cells, and summarizes the advances in the studies of traditional Chinese medicines in the treatment of testicular spermatogenic epithelial injury, aiming to provide a theoretical basis for the selection of relevant medicines and their clinical application.

男性不育症的发病率逐年上升,其中一个主要原因是睾丸生精上皮损伤,它影响了睾丸的生精功能。铁凋亡是一种新的细胞死亡模式,在睾丸细胞损伤中发挥着重要作用。一些中药可通过调节睾丸生精上皮的铁凋亡途径,干预睾丸损伤的进展。本文重点探讨了中药在调节睾丸细胞生铁通路方面的作用,并总结了中药治疗睾丸生精上皮损伤的研究进展,旨在为相关药物的选择和临床应用提供理论依据。
{"title":"[Intervention of traditional Chinese medicine in spermatogenic epithelium injury by regulating the ferroptosis pathway: Advances in studies].","authors":"Jin-Tao Wei, Zi-Yang Ma, Jun Cao, Pei-Hai Zhang","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>The incidence of male infertility has been increasing year by year, and one of the major causes is testicular spermatogenic epithelial injury, which affects the spermatogenic function of the testis. Ferroptosis is a novel mode of cell death and plays an important role in testicular cell injury. Some traditional Chinese medicines can intervene in the progression of testicular injury by regulating the ferroptosis pathway in testicular spermatogenic epithelia. This paper focuses on the effect of traditional Chinese drugs in regulating the ferroptosis pathway in testicular cells, and summarizes the advances in the studies of traditional Chinese medicines in the treatment of testicular spermatogenic epithelial injury, aiming to provide a theoretical basis for the selection of relevant medicines and their clinical application.</p>","PeriodicalId":24012,"journal":{"name":"Zhonghua nan ke xue = National journal of andrology","volume":"30 5","pages":"450-455"},"PeriodicalIF":0.0,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142112775","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Effect and safety of pulsatile GnRH therapy for male congenital hypogonadotropic hypogonadism]. [脉冲性 GnRH 治疗男性先天性性腺功能减退症的效果和安全性]。
Q4 Medicine Pub Date : 2024-05-01
Yong-Hua Niu, Hao Xu, Yin-Wei Chen, Ru-Zhu Lan, Tao Wang, Shao-Gang Wang, Ji-Hong Liu

Objective: To investigate the efficiency and safety of the pulsatile GnRH therapy in the treatment of male congenital hypogonadotropic hypogonadism (CHH).

Methods: We retrospectively analyzed the clinical data on 45 CHH males treated by pulsatile GnRH therapy in our hospital from January 2013 to March 2023. We treated the patients with gonadorelin at 7-15 μg, one pulse/90 min, and followed them up every month in the first 3 months and then every 3 to 6 months after treatment, for an average of 19.1±4.3 months, during which we recorded the height, body weight, penile length, testis volume, Tanner stages, levels of FSH, LH and T, semen parameters and adverse reactions of the patients, followed by comparison of the data obtained with the baseline.

Results: The levels of FSH, LH and T of the patients were dramatically elevated after treatment (P < 0.01). The T level of the 6 cases of cryptorchidism, however, failed to reach the normal value within 18.2 ± 8.6 months of follow-up. Significant improvement was seen in the external genitalia and secondary sexual characteristics of all the patients, and spermatogenesis was observed in the semen in 33 cases (73.3%), with a mean sperm concentration of (18.2 ± 6.2) 10⁶/ml, sperm progressive motility of (19.7 ± 6.5) %, and semen volume of (1.8 ± 0.6) ml. Eight of the cases achieved natural fertility, and another 3 achieved childbirth by assisted reproductive technology. As for adverse events, gynecomastia was observed in 8, subcutaneous induration in 6, and allergic reaction to therapeutic agent in 3 cases.

Conclusion: Pulsatile GnRH therapy is an effective and safe strategy for male CHH. However, clinicians should choose appropriate approaches to different individual cases.

目的探讨脉冲式GnRH疗法治疗男性先天性性腺功能减退症(CHH)的有效性和安全性:我们回顾性分析了2013年1月至2023年3月在我院接受脉冲式GnRH治疗的45名CHH男性患者的临床数据。在此期间,我们记录了患者的身高、体重、阴茎长度、睾丸体积、Tanner分期、FSH、LH和T水平、精液参数和不良反应,并将所得数据与基线进行比较:结果:治疗后,患者的 FSH、LH 和 T 水平显著升高(P < 0.01)。然而,6 例隐睾患者的 T 水平在随访的 18.2 ± 8.6 个月内未能达到正常值。所有患者的外生殖器和第二性征均有明显改善,33 例(73.3%)患者的精液中出现了生精现象,平均精子浓度为(18.2 ± 6.2)10⁶/ml,精子活动率为(19.7 ± 6.5)%,精液量为(1.8 ± 0.6)ml。其中 8 例实现了自然生育,另外 3 例通过辅助生殖技术实现了生育。在不良反应方面,8 例观察到妇科炎症,6 例观察到皮下压痕,3 例观察到对治疗药物的过敏反应:结论:脉冲式 GnRH疗法是治疗男性CHH的一种有效而安全的策略。结论:脉冲式 GnRH疗法是治疗男性CHH的有效而安全的策略,但临床医生应根据不同的病例选择适当的方法。
{"title":"[Effect and safety of pulsatile GnRH therapy for male congenital hypogonadotropic hypogonadism].","authors":"Yong-Hua Niu, Hao Xu, Yin-Wei Chen, Ru-Zhu Lan, Tao Wang, Shao-Gang Wang, Ji-Hong Liu","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Objective: </strong>To investigate the efficiency and safety of the pulsatile GnRH therapy in the treatment of male congenital hypogonadotropic hypogonadism (CHH).</p><p><strong>Methods: </strong>We retrospectively analyzed the clinical data on 45 CHH males treated by pulsatile GnRH therapy in our hospital from January 2013 to March 2023. We treated the patients with gonadorelin at 7-15 μg, one pulse/90 min, and followed them up every month in the first 3 months and then every 3 to 6 months after treatment, for an average of 19.1±4.3 months, during which we recorded the height, body weight, penile length, testis volume, Tanner stages, levels of FSH, LH and T, semen parameters and adverse reactions of the patients, followed by comparison of the data obtained with the baseline.</p><p><strong>Results: </strong>The levels of FSH, LH and T of the patients were dramatically elevated after treatment (P < 0.01). The T level of the 6 cases of cryptorchidism, however, failed to reach the normal value within 18.2 ± 8.6 months of follow-up. Significant improvement was seen in the external genitalia and secondary sexual characteristics of all the patients, and spermatogenesis was observed in the semen in 33 cases (73.3%), with a mean sperm concentration of (18.2 ± 6.2) 10⁶/ml, sperm progressive motility of (19.7 ± 6.5) %, and semen volume of (1.8 ± 0.6) ml. Eight of the cases achieved natural fertility, and another 3 achieved childbirth by assisted reproductive technology. As for adverse events, gynecomastia was observed in 8, subcutaneous induration in 6, and allergic reaction to therapeutic agent in 3 cases.</p><p><strong>Conclusion: </strong>Pulsatile GnRH therapy is an effective and safe strategy for male CHH. However, clinicians should choose appropriate approaches to different individual cases.</p>","PeriodicalId":24012,"journal":{"name":"Zhonghua nan ke xue = National journal of andrology","volume":"30 5","pages":"404-409"},"PeriodicalIF":0.0,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142112774","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Treatment of chronic prostatitis with Xiongji Formula based on the concept of "brain-heart-kidney-essence chamber" axis of medication]. [基于 "脑-心-肾-精室 "用药轴概念的雄鸡方治疗慢性前列腺炎]。
Q4 Medicine Pub Date : 2024-05-01
Zi-Wei Zhao, Qing-He Gao, Yang Liu, Hong-Yuan Chang, Di-Cheng Luo, An-Min Wang, Jun Guo

Chronic prostatitis is a process of kidney deficiency and blood stasis mixed with various pathological factors involving the essence chamber, which is manifested as kidney deficiency and blood stasis. Based on the concept of the "brain-heart-kidney-essence chamber" axis of medication, Xiongji Formula is applied to the treatment of chronic prostatitis, due to its "simultaneous holistic and local action" and effects of tonifying the kidney yang and assisting the systemic yang, acting on the brain, heart and kidney as a whole, and meanwhile activating blood circulation, eliminating blood stasis and restoring the function of the essence chamber. This paper discusses the etiology and pathogenesis of chronic prostatitis with kidney deficiency and blood stasis in Chinese medicine, expounds the significance of "brain-heart-kidney-essence chamber" axis of medication, and explores the specific value and clinical application of Xiongji Formula.

慢性前列腺炎是肾虚血瘀夹杂多种病理因素累及精室,表现为肾虚血瘀的过程。基于 "脑-心-肾-精室 "轴的用药理念,雄鸡方应用于慢性前列腺炎的治疗,因其 "整体与局部同时作用",具有补肾阳、助系统阳的功效,作用于脑、心、肾整体,同时活血化瘀,恢复精室功能。本文论述了中医肾虚血瘀型慢性前列腺炎的病因病机,阐述了 "脑-心-肾-精室 "轴的用药意义,探讨了雄鸡方的具体价值和临床应用。
{"title":"[Treatment of chronic prostatitis with Xiongji Formula based on the concept of \"brain-heart-kidney-essence chamber\" axis of medication].","authors":"Zi-Wei Zhao, Qing-He Gao, Yang Liu, Hong-Yuan Chang, Di-Cheng Luo, An-Min Wang, Jun Guo","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Chronic prostatitis is a process of kidney deficiency and blood stasis mixed with various pathological factors involving the essence chamber, which is manifested as kidney deficiency and blood stasis. Based on the concept of the \"brain-heart-kidney-essence chamber\" axis of medication, Xiongji Formula is applied to the treatment of chronic prostatitis, due to its \"simultaneous holistic and local action\" and effects of tonifying the kidney yang and assisting the systemic yang, acting on the brain, heart and kidney as a whole, and meanwhile activating blood circulation, eliminating blood stasis and restoring the function of the essence chamber. This paper discusses the etiology and pathogenesis of chronic prostatitis with kidney deficiency and blood stasis in Chinese medicine, expounds the significance of \"brain-heart-kidney-essence chamber\" axis of medication, and explores the specific value and clinical application of Xiongji Formula.</p>","PeriodicalId":24012,"journal":{"name":"Zhonghua nan ke xue = National journal of andrology","volume":"30 5","pages":"439-443"},"PeriodicalIF":0.0,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142112780","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Causal relationship between relative abundance of gut microbiota and teratozoospermia: A two-sample Mendelian randomization analysis]. [肠道微生物群相对丰度与畸形精子症之间的因果关系:双样本孟德尔随机分析]。
Q4 Medicine Pub Date : 2024-05-01
Xiao-Hui Hao, Rui-Min Ma, Si-Cheng Ma, Wen-Bang Liu, Chen-Ming Zhang, Wen-Lin Yu, Jing Hu, Zu-Long Wang

Objective: To explore the potential causal relationship between gut microbiota and teratozoospermia.

Methods: We searched the database of Genome-Wide Association Study (GWAS) for gut microbiota- and teratozoospermia-related data. We used gut microbiota as an exposure factor, determined the instrumental variables according to the GWAS data on 18 340 participants released by the MiBioGen Alliance, and derived the outcome variables from the European data on teratozoospermia, with a sample size of 85 716, including 915 cases and 209 006 controls. Using inverse-variance weighting (IVW), MR-Egger regression and the weighted median estimator (WME), we performed two-sample Mendelian randomization (MR) analysis on the retrieved data, and estimated the causal relationship between gut microbiota and teratozoospermia based on the β value.

Results: Two-sample MR analysis indicated that the class Erysipelotrichia, family Erysipelotrichaceae, family Streptococcaceae, genus Coprococcusl, genus Ruminococcaceae UCG009, genus Streptococcus, order Clostridialesm and order Erysipelotrichales were causally related with the increased risk, while the family Porphyromonadaceae with the decreased risk of teratozoospermia.

Conclusion: The class Erysipelotrichia, family Erysipelotrichaceae, family Streptococcaceae, genus Coprococcusl, genus Ruminococcaceae UCG009, genus Streptococcus, order Clostridialesm and order Erysipelotrichales are one of the causes of teratozoospermia, related to the increased risk of the condition, while the family Porphyromonadaceae has a protective effect on sperm morphology, reducing the risk of teratozoospermia.

目的:探讨肠道微生物群与畸形精子症之间的潜在因果关系:探讨肠道微生物群与畸形精子症之间的潜在因果关系:我们在全基因组关联研究(GWAS)数据库中搜索了肠道微生物群与畸形精子症的相关数据。我们将肠道微生物群作为暴露因子,根据 MiBioGen 联盟发布的 18 340 名参与者的 GWAS 数据确定工具变量,并从欧洲畸形精子症数据中得出结果变量,样本量为 85 716 个,包括 915 个病例和 209 006 个对照。利用逆方差加权(IVW)、MR-Egger回归和加权中位数估计器(WME),我们对检索到的数据进行了双样本孟德尔随机化(MR)分析,并根据β值估计了肠道微生物群与畸形精子症之间的因果关系:结果:双样本MR分析表明,Erysipelotrichia类、Erysipelotrichaceae科、Streptococcaceae科、Coprococcusl属、Ruminococcaceae UCG009属、Streptococcus属、Clostridialesm目和Erysipelotrichales目与畸形精子症风险增加有因果关系,而Porphyromonadaceae科与畸形精子症风险降低有因果关系:结论:Erysipelotrichia 类、Erysipelotrichaceae 科、Streptococcaceae 科、Coprococcusl 属、Ruminococcaceae UCG009 属、Streptococcus 属、Clostridialesm 目和 Erysipelotrichales 目是导致畸形精子症的原因之一,与畸形精子症风险的增加有关,而 Porphyromonadaceae 科对精子形态具有保护作用,可降低畸形精子症的风险。
{"title":"[Causal relationship between relative abundance of gut microbiota and teratozoospermia: A two-sample Mendelian randomization analysis].","authors":"Xiao-Hui Hao, Rui-Min Ma, Si-Cheng Ma, Wen-Bang Liu, Chen-Ming Zhang, Wen-Lin Yu, Jing Hu, Zu-Long Wang","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Objective: </strong>To explore the potential causal relationship between gut microbiota and teratozoospermia.</p><p><strong>Methods: </strong>We searched the database of Genome-Wide Association Study (GWAS) for gut microbiota- and teratozoospermia-related data. We used gut microbiota as an exposure factor, determined the instrumental variables according to the GWAS data on 18 340 participants released by the MiBioGen Alliance, and derived the outcome variables from the European data on teratozoospermia, with a sample size of 85 716, including 915 cases and 209 006 controls. Using inverse-variance weighting (IVW), MR-Egger regression and the weighted median estimator (WME), we performed two-sample Mendelian randomization (MR) analysis on the retrieved data, and estimated the causal relationship between gut microbiota and teratozoospermia based on the β value.</p><p><strong>Results: </strong>Two-sample MR analysis indicated that the class Erysipelotrichia, family Erysipelotrichaceae, family Streptococcaceae, genus Coprococcusl, genus Ruminococcaceae UCG009, genus Streptococcus, order Clostridialesm and order Erysipelotrichales were causally related with the increased risk, while the family Porphyromonadaceae with the decreased risk of teratozoospermia.</p><p><strong>Conclusion: </strong>The class Erysipelotrichia, family Erysipelotrichaceae, family Streptococcaceae, genus Coprococcusl, genus Ruminococcaceae UCG009, genus Streptococcus, order Clostridialesm and order Erysipelotrichales are one of the causes of teratozoospermia, related to the increased risk of the condition, while the family Porphyromonadaceae has a protective effect on sperm morphology, reducing the risk of teratozoospermia.</p>","PeriodicalId":24012,"journal":{"name":"Zhonghua nan ke xue = National journal of andrology","volume":"30 5","pages":"387-396"},"PeriodicalIF":0.0,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142112771","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
中华男科学杂志
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1